Applonia Rose/LinkedIn
Jan 12, 2025, 15:42
Applonia Rose: Let’s turn awareness into action
Applonia Rose, Managing Editor at Sage, shared a post on LinkedIn:
“January 11 marks Less Survivable Cancers Awareness Day (LSCAD), dedicated to raising awareness of cancers with the lowest survival rates and advocating for progress in their diagnosis and treatment.
These conditions remain some of the hardest to address, making LSCAD a vital call for action – to promote early detection and advance research.
At Technology in Cancer Research and Treatment (TCRT), we support this mission by publishing high-quality research and join in the efforts to improve outcomes for those affected.
Here are a few impactful studies worth mentioning:
- The Rise of Extracellular Vesicles as New Age Biomarkers in Cancer Diagnosis: Promises and Pitfalls.
- Robotics in Interventional Radiology: Review of Current and Future Applications.
- Transarterial Chemoembolization Combined With PD-1 Inhibitors Plus Lenvatinib Showed Improved Efficacy for Treatment of Unresectable Hepatocellular Carcinoma Compared With PD-1 Inhibitors Plus Lenvatinib.
- Microfluidics for Profiling miRNA Biomarker Panels in AI-Assisted Cancer Diagnosis and Prognosis.
- Focused Ultrasound and Ultrasound Stimulated Microbubbles in Radiotherapy Enhancement for Cancer Treatment.
Let’s turn awareness into action.”
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Jan 12, 2025, 15:42
Jan 12, 2025, 15:23
Jan 12, 2025, 15:12
Jan 12, 2025, 15:08
Jan 12, 2025, 15:03
Jan 12, 2025, 13:47